Crotalus durissus terrificus venom interferes with morphological, functional, and biochemical changes in murine macrophage

Mediators of Inflammation

Volumn 2005, Issue 6, 2005, Pages 349-359

  Cruz, Anselmo Hernández ^a   Mendonça, Ronaldo Z ^b   Petricevich, Vera L ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE; PHENOLSULFONPHTHALEIN; SNAKE VENOM; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL FUNCTION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SUPERNATANT;

ANIMALS; CELL SHAPE; CROTALID VENOMS; CROTALUS; CYTOKINES; FEMALE; HYDROGEN PEROXIDE; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; OXIDANTS; PHAGOCYTOSIS; VACUOLES;

ANIMALIA; ARMORACIA RUSTICANA; CROTALUS DURISSUS TERRIFICUS; EUKARYOTA; MURINAE;

EID: 29144437224     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.349     Document Type: Article

References (45)

1. Kamiguti AS, Cardoso JL. Haemostatic changes caused by the venoms of South American snakes. Toxicon. 1989;27(9):955-963.
2. Oshima-Franco Y, Hyslop S, Prado-Franceschi J, Cruz-Hofling MA, Rodrigues-Simioni L. Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and itsmain toxin, crotoxin. Toxicon. 1999;37(10):1341-1357.
3. Rodríguez Acosta A, Uzcategui W, Aguaje R, Aguilar I, Giron ME. Analisis clinico y epidemiologico de los accidentes por mordeduras de serpientes del genero Bothrops en Venezuela [A clinical and epidemiological analysis of accidental bites by snakes of the genus Bothrops in Venezuela]. Rev Cubana Med Trop. 2000;52(2):90-94.
4. Pulido-Mendez M, Rodríguez-Acosta A, Finol HJ, Aguilar I, Giron ME. Ultrastructural pathology in skeletal muscle of mice envenomed with Crotalus vegrandis venom. J Submicrosc Cytol Pathol. 1999;31(4):555-561.
5. Rodríguez-Acosta A, Pulido-Mendez M, Finol HJ, Giron ME, Aguilar I. Liver ultrastructural pathology in mice envenomed with Uracoan rattlesnake (Crotalus vegrandis) venom. J Submicrosc Cytol Pathol. 1999;31(3):433-439.
6. Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991;29(11):1279-1303.
7. Lomonte B, Gutierrez JM, Romero M, Nunez J, Tarkowski A, Hanson LA. An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. J Immunol Methods. 1993;161(2):231-237.
8. Barros SF, Friedlanskaia I, Petricevich VL, Kipnis TL. Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom. Mediators Inflamm. 1998;7(5):339-346.
9. Petricevich VL, Teixeira CF, Tambourgi DV, Gutierrez JM. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon. 2000;38(9):1253-1266.
10. Tambourgi DV, Petricevich VL, Magnoli FC, Assaf SL, Jancar S, Dias Da Silva W. Endotoxemic-like shock induced by Loxosceles spider venoms: pathological changes and putative cytokine mediators. Toxicon. 1998;36(2):391-403.
11. Petricevich VL. Cytokine and nitric oxide production following severe envenomation. Curr Drug Targets Inflamm Allergy. 2004;3(3):325-332.
12. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998;351(9107):950-953.
13. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med. 1999;17(6):548-551.
14. Coffman RL, Mosmann TR. CD4 + T-cell subsets: regulation of differentiation and function. Res Immunol. 1991;142(1):7-9.
15. Jo T, Terada N, Takauchi Y, et al. Cytotoxic actions of cytokines on cultured mouse luteal cells are independent of nitric oxide. J Steroid Biochem Mol Biol. 1995;55(3-4):291-296.
16. Stein M, Gordon S. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors. Eur J Immunol. 1991;21(2):431-437.
17. Van der Meide PH, Schellekens H. Cytokines and the immune response. Biotherapy. 1996;8(3-4):243-249.
18. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993;177(2):547-550.
19. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993;177(4):1205-1208.
20. Cardoso DF, Mota I. Effect of Crotalus venom on the humoral and cellular immune response. Toxicon. 1997;35(4):607-612.
21. Sampaio SC, Brigatte P, Sousa-e-Silva MC, et al. Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon. 2003;41(7):899-907.
22. Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol. 2001;70(4):551-558.
23. International Society on Toxicology. Toxicon. 1992;30:1-12.
24. Cohn ZA, Benson B. The differentiation of mononuclear phagocytes: morphology, cytochemistry, and biochemistry. J Exp Med. 1965;121:153-170.
25. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46(2):2111-2126.
26. Zebedee SL, Koduri RK, Mukherjee J, et al. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother. 1994;38(7):1507-1514.
27. Arruda MS, Richini VB, Oliveira SM, Vilani-Moreno FR. Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in thalidomide-treated mice. Braz J Med Biol Res. 2004;37(4):485-492.
28. Keller R, Keist R, Wechsler A, Leist TP, van der Meide PH. Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor. Int J Cancer. 1990;46(4):682-686.
29. Schumacher JH, O'Garra A, Shrader B, et al. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J Immunol. 1988;141(5):1576-1581.
30. Ruff MR, Gifford GE. Purification and physicochemical characterization of rabbit tumor necrosis factor. J Immunol. 1980;125(4):1671-1677.
31. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79(2):319-326.
32. Jedynak M, Siemiatkowski A. The role of monocytes/macrophages and their cytokines in the development of immunosuppression after severe injury. Pol Merkuriusz Lek. 2002;13(75):238-241.
33. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol. 1984;2:283-318.
34. Barth MW, Hendrzak JA, Melnicoff MJ, Morahan PS. Review of the macrophage disappearance reaction. J Leukoc Biol. 1995;57(3):361-367.
35. Arandjelovic S, Bogic M, Raskovic S. The role of mononuclear phagocytes and dendritic cells in allergic inflammation. Srp Arh Celok Lek. 1998;126(1-2):46-53.
36. Desjardins M, Celis JE, van Meer G, et al. Molecular characterization of phagosomes. J Biol Chem. 1994;269(51):32194-32200.
37. Russell DG. Mycobacterium and Leishmania: stow-aways in the endosomal network. Trends Cell Biol. 1995;5(3):125-128.
38. Nacife VP, Soeiro M de N, Gomes RN, D'Avila H, Castro-Faria Neto HC, Meirelles M de N. Morphological and biochemical characterization of macrophages activated by carrageenan and lipopoly- saccharide in vivo. Cell Struct Funct. 2004;29 (2):27-34.
39. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593-623.
40. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 1990;4(11):2860-2867.
41. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med. 1995;43(3):227-235.
42. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 1991;163(6):1177-1183.
43. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129-163.
44. Nathan ÇF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3(1):65-70.
45. Nathan Ç, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78(6):915-918.